GuidelineHepatology (Baltimore, Md.)2015

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.

Arun J Sanyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.